ABOUT YUKTI GENOMICS
Yukti Genomics AI Private Limited is a deeptech genomics intelligence company building AI-enabled platforms for precision medicine, molecular diagnostics and clinical genomics.
We are focused on one of the most important challenges in modern healthcare: converting complex genomic data into clinically meaningful, evidence-linked and expert-reviewable insights.
To Make Genomic Intelligence Scalable, Responsible and Clinically Useful
Our mission is to help diagnostic labs, hospitals, clinicians and researchers transform genomic data into structured insights that support precision medicine workflows.
We aim to make advanced genomic interpretation more accessible to institutions that want to scale precision medicine without being limited by fragmented bioinformatics infrastructure, scarce expert capacity or manual reporting bottlenecks.
OUR DEEPTECH THESIS
The future of genomic medicine will not be driven by sequencing data alone. It will be driven by platforms that can:
Interpret molecular variants in clinical context
Support expert-led review workflows
Generate clinician-readable reports
Integrate with diagnostic labs and hospital systems
Connect findings to guideline and literature-backed actionability
Perform Population aware Genomic Intelligence
Combining genomic expertise, responsible AI, and evidence-driven workflows to deliver scalable, clinician-ready insights for precision medicine.
We understand the practical realities of genomic testing: data quality, variant complexity, interpretation burden, reviewer dependency and clinical report usability.
Our platforms are designed to use AI responsibly across evidence summarization, variant prioritization, report structuring and workflow automation.
We prioritize traceability, source-backed interpretation, guideline alignment and review-ready outputs.
Our work is centered on the final mile of genomics: making findings understandable, usable and reviewable by clinical teams.
India offers a uniquely demanding environment: high price sensitivity, rising genomics adoption, diverse populations and scalable healthcare needs.
Our architecture is being designed for future enterprise deployment, API integration, multi-center workflows and multi-omics expansion.
SCIENTIFIC ADVISORY BOARD
Yukti Genomics is building its Scientific Advisory Board to bring together experts across
clinical genomics, oncology, molecular pathology, bioinformatics, rare disease,
pharmacogenomics and translational medicine.
The advisory board supports the company in clinical workflow relevance, report
interpretation quality, oncology actionability frameworks, rare disease and WES
interpretation workflows, pharmacogenomics use cases, evidence review standards, validation
design, responsible AI and clinical governance.
To Build a Global Intelligence Platform for Genomics and Multi-Omics Medicine.
We envision Yukti Genomics as a trusted platform company powering the next generation of precision medicine.
Our long-term vision is to build a multi-omics intelligence layer that integrates genomics, clinical context, molecular evidence, therapeutic relevance and real-world data into reviewable workflows for clinical and translational use.
We welcome collaboration with diagnostic labs, hospitals, oncologists, geneticists, molecular pathologists, bioinformaticians, researchers, investors and ecosystem partners.
Talk to Our Team